We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERICS LAUNCH METFORMIN ER IN 'SECOND-TIER' EXCLUSIVITY
GENERICS LAUNCH METFORMIN ER IN 'SECOND-TIER' EXCLUSIVITY
June 21, 2004
Several generic firms last week launched versions of Bristol-Myers Squibb’s (BMS’) Type 2 diabetes drug Glucophage XR, 500-mg strength tablets, under a “second tier” of 180-day marketing exclusivity.